ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.
ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.
复制标题
DOI：
10.1188/22.onf.279-295
复制
发表时间：
2022-06-17
影响因子：
1.9
通讯作者：
Morgan, Rebecca L.
中科院分区：
文献类型：
--
作者：
Belcher, Sarah M.;Mackler, Emily;Muluneh, Benyam;Ginex., Pamela K.;Anderson, Mary K.;Bettencourt, Elizabeth;DasGupta, Ryan K.;Elliott, Jennifer;Hall, Erica;Karlin, Michelle;Kostoff, Diana;Marshall, Victoria K.;Millisor, Vanessa E.;Molnar, Maegan;Schneider, Susan M.;Tipton, Janelle;Yackzan, Susan;LeFebvre, Kristine B.;Sivakumaran, Kapeena;Waseem, Haya;Morgan, Rebecca L.
该循证指南旨在为患者、临床医生和其他人提供干预措施和流程方面的支持，以支持患者坚持口服抗癌药物 (OAM)。由医疗保健专业人员和患者代表组成的小组制定了临床实践指南，以支持患者服用 OAM。遵循 GRADE（建议评估、制定和评估分级）方法和可信指南标准。使用 Cochrane 偏差风险 2 工具评估偏差风险。证据的定量或叙述性综合已经完成。使用 GRADE 评估证据的确定性。小组就建议达成了一致，并建议除常规护理外，还应进行依从性风险评估、针对依从性的教育、持续评估、主动随访、辅导和动机访谈。该小组建议实施结构化的 OAM 计划。随着癌症治疗从诊所转向家庭环境，需要采取干预措施和计划来支持 OAM 患者。
This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence to oral anticancer medications (OAMs). A panel of healthcare professionals and patient representatives developed a clinical practice guideline to support patients taking OAMs. GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology and criteria for trustworthy guidelines were followed. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. A quantitative or narrative synthesis of the evidence was completed. Certainty of the evidence was assessed using GRADE. The panel agreed on recommendations and suggested an adherence risk assessment, education addressing adherence, ongoing assessment, proactive follow-up, coaching, and motivational interviewing in addition to usual care. The panel suggested the implementation of a structured OAM program. As cancer treatment shifts from clinic to home settings, interventions and programs to support patients on OAMs are needed.
DOI：
10.1177/1078155220960800
发表时间：
2021-09
期刊：
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
影响因子：
--
作者：
Lin M;Hackenyos D;Savidge N;Weidner RA;Murphy-Banks R;Fleckner T;Parsons SK;Rodday AM
通讯作者：
Rodday AM